ITI-214 free base
Based on 3 publication(s) in Google Scholar
ITI-214 free base is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 free base inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 free base shows efficacy in various animal models of motor and cognitive functions.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 98.0%
- CAS 番号: 1160521-50-5
- 分子式: C29H26FN7O
- 分子量:507.56
-
保管条件:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
MedChemExpress(MCE)の使用を引用している文献 ITI-214 free base
More-
ELISA
-
WB
-
In Vivo Efficacy Study
生物活性
製品説明
IC50 & Target
[1]|
PDE1 58 pM (Ki) |
PDE1A 33 pM (Ki) |
PDE1B 380 pM (Ki) |
PDE1C 35 pM (Ki) |
体外実験
ITI-214 is found to potently inhibit the activity of full-length recombinant r-hPDE1A (Ki= 34 pM), r-hPDE1B (Ki= 380 pM), and r-hPDE1C (Ki= 37 pM) enzymes transiently expressed in HEK cells. The compound expressed >1000-fold greater activity toward PDE1 isoforms compared with the next nearest PDE family enzyme, PDE4D (Ki= 33 nM) and 10,000-300,000-fold selectivity toward all other PDE enzyme families[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Sprague-Dawley rats[1]
-
Dosage:0.1-10 mg/kg
-
Administration:P.o.
-
Result:Significantly enhanced memory performance in the test with a minimum effective dose of 3 mg/kg.
化学情報
-
CAS 番号 1160521-50-5
-
性状 Solid
-
分子量 507.56
-
分子式 C29H26FN7O
-
Color White to off-white
-
SMILES
O=C(C1=C(NC2=CC=CC=C2)N(CC3=CC=C(C4=NC(F)=CC=C4)C=C3)N=C1N56)N(C)C5=N[C@@]7([H])[C@]6([H])CCC7
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Sci Adv
2024 Jan 5;10(1):eadi2689. PMID: 38170777
ITI-214 free base purchased from MedChemExpress. Usage Cited in: Sci Adv. 2024 Jan 5;10(1):eadi2689. [Abstract]
Effects of the PDE1 inhibitor ITI-214 (1 μM; 1 h pre-incubation followed by 20 min ANP stimulation in the continued presence of ITI-214) on ANP-stimulated cGMP levels in untransfected or siC versus siZ adipocytes. ITI-214 increased cGMP levels and eliminated the difference in cGMP levels between ZNF189-depleted and control cells.
-
Cells
Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes. [Abstract]2023 Dec 3;12(23):2759. PMID: 38067187
ITI-214 free base purchased from MedChemExpress. Usage Cited in: Cells. 2023 Dec 3;12(23):2759. [Abstract]
PDE1 inhibition with ITI-214 (1 μM; 10 min) amplified phospholamban (PLN) phosphorylation at Ser16 upon CNP and SNP stimulation.
-
ITI-214 free base purchased from MedChemExpress. Usage Cited in: Patent. US20230111925A1.
Body-weight changes, survival rates, colon lengths, and disease activity index (DAI) scores in 2% DSS-induced C57BL/6 mice administered ITI-214 (PDE1i; 3 mg/kg; i.p.; twice daily on days 4-8).
純度とドキュメンテーション
-
データシート (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Li P, et al. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. J Med Chem. 2016 Feb 11;59(3):1149-64. [Content Brief]
[2]. Lawrence Wennogle. Novel uses. From PCT Int. Appl. (2014), WO 2014145617 A2 20140918.
[3]. Peng Li , et al. Salt crystals. From PCT Int. Appl. (2013), WO 2013192556 A2 20131227.
[4]. Allen A. Fienberg, et al. Organic compounds. From PCT Int. Appl. (2010), WO 2010132127 A1 20101118.
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)